Advaxis, Inc. - "Advaxis Immunotherapies Complement PD-1 Antibodies" MarketWatch Feb 18, 2014 (ACCESSWIRE via COMTEX) -- Advaxis Inc. (NASDAQ:ADXS) today published a new blog post on The Chairman's Blog, written by the company's CSO, Dr. Robert Petit. TheChairmansBlog.com is an exclusive online media publication that ... Advaxis, Inc. - “Advaxis Immunotherapies Complement PD-1 Antibodies” |
